Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Add To Watchlist

Bullboard (TSX:VRX)

View:

Post by MNK3240on Jan 12, 2018 3:49pm

Valeant seems to be ready for big blast

Last week or so it's been consolidating around $29/30 and holding it's position both at bad and good news. Seems ready to take off. Anybody has short position, close it, otherwise, soon you ...more

211

Comment by RipCrackleon Jan 11, 2018 5:41pm

RE:When the bonds come due it's game over

oh no, did you blow up your portfolio by shorting this when smart money already covered a long time ago? rookie

103

Discussion

Post by johnnywickon Jan 11, 2018 12:40pm

I TOLD U DON'T SHORT THIS STOCK

lots of new high coming... don't miss it

Post by johnnywickon Jan 11, 2018 12:38pm

@@@ ATTENTION ATTENTION.. VALEANT IS READY FOR BLASTOFF @@@

10... 9... 8.. 7 ... 6 ... 5....4......3

Post by johnnywickon Jan 11, 2018 12:29pm

@@@ THE LAST TECHNICAL RESISTANCE BROKEN @@@

Valeant ready for BLAST OFF buckle yoor seatbelt.. oh yeah !!!

Post by RipCrackleon Jan 04, 2018 8:38am

Good job management in paying down massive amount of debt

from cash flow, no less!

137

Post by johnnywickon Jan 02, 2018 8:14pm

U short this stock now, you going to be coughing blood later

don't short VRX go long !!

155

Comment by johnnywickon Jan 02, 2018 8:11pm

RE:2012 VALEANT $56.00 with a B1 rating from Moody

don't be a fool this company valeant going to be $100.00 again in the near future debt talk / moody junk rating.. they're meaningless focus on what's already out of the pipeline and ...more

250

Discussion

Post by johnnywickon Jan 02, 2018 8:03pm

2012 VALEANT $56.00 with a B1 rating from Moody

2012 Valeant was trading at $56.00 with a B1 rating from Moody Total 2012 revenue was $3.55 billion Now Valeant have close to 3X more revenue than 2012 and the rating is pretty much the same.. on top ...more

261

Discussion

Post by johnnywickon Jan 02, 2018 6:57pm

3 new drugs from last year.. all taking off

even the old drugs that shows lagging sales are rebounding BIG TIME, back on the growth track VRX got $50-$60 written all over it

140

Post by johnnywickon Jan 02, 2018 6:50pm

EPS CONCENSUS 0.90 /// VALEANT CAME IN AT 1.04 ( HUGE BEAT )

SHORTS... the coming earnings going to be far more powerful than the last blow out earnings. VRX heading to $50-$60

147

Post by johnnywickon Jan 02, 2018 6:45pm

all the people doubting CEO papa already proven wrong

all the people doubting CEO papa of turning Valeant around already proven wrong the tsnami of bashing of valeant and its new ceo ... around $10 ( this is the time i told everyone to buy valeant ...more

147